A Billionaire-Backed Startup Just Pitched Growing Your Brainless Clone as a Spare Body
A Billionaire-Backed Startup Just Pitched Growing Your Brainless Clone as a Spare BodyA stealth company called R3 Bio told rich people they could grow a copy of themselves — without a brain — and swap their old body for the new one. MIT Technology Review found the receipts.
A California startup backed by billionaire money has been secretly pitching “body replacement cloning” — growing a full human clone minus the brain, then transplanting your brain into the younger body. The company publicly claims it’s just making monkey “organ sacks” for lab testing. The private pitch deck tells a very different story.
The company is called R3 Bio. One attendee at their private presentation compared the experience to “a meeting with Dr. Strangelove.” Human cloning is illegal in most countries. Nobody has cloned a primate from adult cells. Artificial wombs don’t exist. But here’s the thing nobody mentions: the fact that someone with real money is funding this means the longevity crowd has moved past supplements and stem cells — they want spare bodies.
🧩 Dumb Mode Dictionary
| Term | What It Actually Means |
|---|---|
| Body replacement cloning | Growing a copy of your body (no brain), then moving your brain into it |
| Organ sack | A lab-grown body without a brain — just organs ready for harvest |
| Stealth startup | A company that hides what it’s really doing until it’s ready to go public |
| Non-sentient | Can’t think, feel, or experience anything — no consciousness |
| Somatic cell cloning | Copying a full organism from a regular body cell (like how Dolly the sheep was made) |
| Artificial womb | A machine that could grow a baby outside a human body — doesn’t exist yet |
| Longevity crowd | Rich people obsessed with living way longer than normal |
🔍 What R3 Bio Actually Told People Behind Closed Doors
MIT Technology Review investigated the company and found founder John Schloendorn had been running private seminars for longevity enthusiasts for years. The pitch:
- Step 1: Clone your body from your own cells
- Step 2: Prevent the brain from developing (so it’s not a “person”)
- Step 3: Grow it to full size
- Step 4: Transplant your brain into the new body
- Step 5: Live again, younger
The public story? R3 Bio says it raised money to make non-sentient monkey organ sacks — basically organ farms without consciousness — as replacements for animal testing. The private story is the brain-swap thing.
Cofounder Alice Gilman said the team “reserves the right to hold hypothetical futuristic discussions.” Which is a wild way to deny something while also confirming it.
📊 The Receipts — What's Real vs. What's Fantasy
| Claim | Reality |
|---|---|
| Human body cloning | Nobody has cloned a human. Period. |
| Primate cloning from adult cells | Never been done. Dolly the sheep worked in 1996, but primates are way harder |
| “Organ sacks” | Theoretically possible for small structures, never demonstrated at full-body scale |
| Artificial wombs | Don’t exist. You’d need a surrogate mother to carry the clone |
| Brain transplant | Has never been performed successfully on any mammal |
| Billionaire backing | Real. The money is flowing, even if the science isn’t there yet |
Jose Cibelli, a cloning researcher at Michigan State who worked on early human embryo cloning, told Futurism: “There are so many barriers… from illegality and safety issues to the fact that an artificial womb remains science fiction.”
He added: “You’d have to convince a woman to carry a fetus that is going to be abnormal.”
🗣️ What People Are Saying
- R3 Bio’s official denial: “Any allegations of intent or conspiracy to create human clones or humans with brain damage are categorically false.”
- Schloendorn (in a 2024 LinkedIn message to MIT Tech Review): “We will try to do it in a way that produces defined societal benefits early on, and we need to be prepared to take no for an answer.”
- Anonymous attendee of the private pitch: compared it to “a close encounter of the third kind” crossed with “Dr. Strangelove.”
- Bioethicists: Generally horrified. Even the “no brain” angle doesn’t solve the fundamental problem — you still need a human surrogate to carry the clone to term.
🧠 But Here's the Thing Nobody Mentions
The science is nowhere close. But the MONEY is already here. That gap is the actual story.
The longevity industry hit roughly $44 billion in 2024 and it’s growing fast. Billionaires like Bryan Johnson (the “don’t die” guy) are already spending millions per year on age-reversal protocols. When someone with that kind of money hears “we can grow you a new body,” they don’t think “that’s impossible” — they think “how much and when?”
R3 Bio represents the far edge of a very real trend: the ultra-wealthy are funding biological moonshots that would’ve been considered insane 5 years ago. Organ-on-a-chip companies, xenotransplantation (pig organs in humans), and synthetic biology startups are all pulling in billions. R3 just said the quiet part out loud.
Whether or not R3 Bio ever grows a single organ sack, they’ve already done something: they’ve moved the window of what rich people consider “fundable” in biotech. And that changes what gets built next.
⚖️ Why This Should Make You Uncomfortable Even If It Never Works
A few things worth sitting with:
- Legal grey zone: Human cloning is banned in many countries but NOT federally banned in the US. Some states have laws, many don’t. If someone grows a “non-sentient organ structure” from your cells, is it a person? Current law has no answer.
- Consent and surrogacy: You’d need women to carry these clones. That creates an entire economy of surrogates for organ farming. Think about who’d sign up for that.
- Genetic data: To clone you, they need your complete DNA. That’s the most personal data that exists. Where does it go? Who owns it?
- Two-tier biology: If this EVER works, even partially (say, just growing replacement organs from your own cells), it’ll be available to billionaires first. Everyone else gets the waitlist.
Cool. So Silicon Valley Wants to Grow Spare Bodies for Billionaires. Now What the Hell Do We Do? (⊙_⊙)
🧫 The Organ Waitlist Arbitrage
There are 100,000+ people on the US organ transplant waitlist right now. Every company working on synthetic organs, pig-to-human transplants, or 3D-printed tissue needs one thing: someone who understands the regulatory pathway AND can translate it for investors. R3 Bio’s pitch — regardless of how sci-fi it sounds — just made every OTHER organ company look reasonable by comparison. That “Overton window” shift means funding is about to flow into the more realistic organ-growing startups. The play: become the analyst who tracks, compares, and reports on these companies before the finance crowd catches up.
Example: 26-year-old biotech grad in Bangalore scrapes SEC filings and ClinicalTrials.gov data on every xenotransplantation and synthetic organ startup. Publishes a weekly paid Substack ranking them by regulatory progress, funding runway, and technical feasibility. Charges $15/month. Hits 800 subscribers in 6 weeks because VCs and biotech analysts need someone doing this specific tracking.
Timeline: First subscribers in 2 weeks. Sustainable income at 500+ subs (~$7,500/month) in 6-8 weeks. Ceiling depends on whether you expand into a proper research service.
🕳️ The Genetic Privacy Panic Play
Here’s the move nobody’s thinking about: every time a story like R3 Bio drops, a wave of people suddenly google “who has my DNA data” and “how to delete genetic data.” 23andMe already went bankrupt and sold 15 million people’s DNA profiles. The fear is REAL and the tools to protect yourself barely exist. Build a simple site that walks people through requesting deletion of their genetic data from every major database — 23andMe, Ancestry, GEDmatch, law enforcement databases, research biobanks. Charge nothing for the guide, monetize with affiliate links to privacy-focused DNA testing alternatives and VPN services.
Example: 22-year-old in Lisbon builds “DeleteMyDNA.com” — a step-by-step tool showing exactly which companies have your genetic data and auto-generating GDPR/CCPA deletion request emails. Launches on Reddit r/privacy the week the R3 Bio story peaks. Gets 40,000 visits in 3 days. VPN affiliate links convert at 4%, netting ~$3,200 in the first month.
🎰 The Longevity Investor Newsletter Flip
The longevity industry is where crypto was in 2016 — tons of money flowing in, almost zero reliable information for retail investors. Every time a company like R3 Bio makes headlines, thousands of people think “how do I invest in this space?” and find… nothing useful. The play: aggregate every longevity startup’s funding round, clinical trial result, and regulatory filing into a weekly digest. Don’t give investment advice — just organized information that doesn’t exist anywhere else in one place. Think of it as the “Morning Brew” but only for anti-aging biotech.
Example: 28-year-old in São Paulo with basic research skills uses Crunchbase free tier + Google Scholar alerts to track every longevity company. Formats it into a clean weekly email. Grows to 2,000 free subscribers, converts 5% to a $20/month “deep dive” tier. That’s $2,000/month within 10 weeks, and the content compounds — each issue makes the archive more valuable.
📡 The Bioethics Expert-on-Demand Hustle
Every news outlet covering this story needed a bioethicist to quote. Most journalists don’t have one on speed dial. They google, email 10 professors, and 2 respond in time. The play: build a simple “rent-a-quote” directory of bioethics academics, researchers, and commentators. Journalists get fast access to credible sources. Experts get media exposure. You take a cut — either a flat monthly listing fee from experts or a per-booking fee from media outlets. This model already works for ExpertFile and similar platforms, but NOBODY has built one laser-focused on bioethics, which is about to be the hottest beat in journalism.
Example: 24-year-old journalism grad in Nairobi emails 200 bioethics professors globally, offering free listings. Gets 60 sign-ups. Builds a simple Notion directory. Pitches it to health/science reporters at 5 major outlets. Three start using it regularly. Switches to $50/month per expert listing once demand is proven. Revenue: $3,000/month at 60 paying experts.
🪟 The Surrogate Economy Watchdog
If body cloning or even advanced organ farming ever moves forward, it will need surrogates. That conversation is going to EXPLODE in the next 2-3 years as synthetic biology advances. Right now, surrogacy laws are a mess — different in every country, every US state, and most people don’t understand them at all. Build the definitive surrogacy law comparison database. Every country, every state, updated in real time. Free to browse, monetized through legal referral partnerships (surrogacy lawyers pay $200-500 per qualified lead). The R3 Bio story just guaranteed that surrogacy + biotech is going to be a Google search trend for years.
Example: 30-year-old paralegal in Manila builds “SurrogacyLaws.info” using public legal databases and Cornell Law’s LII. Covers 50 countries and all US states. SEO targets “surrogacy laws [country]” keywords that currently have weak competition. Gets 15,000 monthly organic visitors within 3 months. Converts 0.5% to legal consultation requests at $300/referral = $22,500/month.
🛠️ Follow-Up Actions
| Step | Action |
|---|---|
| 1 | Read the full MIT Technology Review investigation — it’s the most detailed source |
| 2 | Check whether your genetic data is sitting in any database using haveibeenpwned.com and contact 23andMe/Ancestry for deletion |
| 3 | Follow the xenotransplantation space — pig-to-human organ transplants are already happening and that’s where the real near-term money is |
| 4 | Set Google Alerts for “R3 Bio,” “body replacement cloning,” and “organ sack” to stay ahead of developments |
| 5 | If you’re in biotech/pharma, the regulatory landscape around synthetic organisms is about to shift — FDA.gov has the latest guidance documents |
Quick Hits
| Want… | Do This |
|---|---|
| Understand the science |
Read the Futurism breakdown — best plain-English summary |
 Protect your DNA data |
Request deletion from 23andMe, Ancestry, GEDmatch — use GDPR/CCPA rights |
 Follow the money |
Track longevity startups on Crunchbase — filter by “synthetic biology” and “organ transplant” |
 Stay updated |
Set alerts for xenotransplantation and synthetic biology FDA approvals |
| Go deeper |
Look into the Overton window effect — R3 Bio’s real impact is making everything ELSE seem normal |
A startup just pitched growing brainless copies of rich people. The science says “not yet.” The money says “how much?” And the ethics board left the building about three funding rounds ago.
!